Long-term results of aortic valve replacement with the St. Jude Toronto stentless porcine valve

Annals of Thoracic Surgery

Volumn 78, Issue 6, 2004, Pages 2076-2083

  Desai, Nimesh D ^a   Merin, Ofer ^a   Cohen, Gideon N ^a   Herman, Jaclyn ^a   Mobilos, Sofia ^a   Sever, Jeri Y ^a   Fremes, Stephen E ^a   Goldman, Bernard S ^a   Christakis, George T ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

35

Indexed keywords

ADULT; AGED; AORTA STENOSIS; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; ARTICLE; CORONARY ARTERY BYPASS GRAFT; EMBOLISM; ENDOCARDITIS; FEMALE; FOLLOW UP; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE DISEASE; MORTALITY; OPERATION DURATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REOPERATION; SURVIVAL RATE; SURVIVAL TIME; SWINE; TIME SERIES ANALYSIS; TREATMENT OUTCOME;

ACTUARIAL ANALYSIS; ADULT; AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; BIOPROSTHESIS; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; PROSTHESIS DESIGN; SURVIVAL ANALYSIS;

EID: 9344264599     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2004.05.061     Document Type: Article

References (25)

1. Jin X.Y., Gibson D.G., Yacoub M.H., Pepper J.R. Perioperative assessment of aortic homograft, Toronto stentless valve, and stented valve in the aortic position. Ann Thorac Surg. 60:(Suppl):1995;S395-401
2. Cohen G., Christakis G.T., Joyner C.D., et al. Are stentless valves hemodynamically superior to stented valves? A prospective randomized trial. Ann Thorac Surg. 73:2002;767-775
3. Santini F., Bertolini P., Montalbano G., et al. Hancock versus stentless bioprosthesis for aortic valve replacement in patients older than 75 years. Ann Thorac Surg. 66:(Suppl):1998;S99-103
4. Williams R.J., Muir D.F., Pathi V., MacArthur K., Berg G.A. Randomized controlled trial of stented and stentless aortic bioprostheses hemodynamic performance at 3 years. Semin Thorac Cardiovasc Surg. 11:(Suppl 1):1999;93-97
5. David T.E., Bos J., Rakowski H. Aortic valve replacement with the Toronto SPV bioprosthesis. J Heart Valve Dis. 1:1992;244-248
6. Goldman B.S., David T.E., Wood J.R., et al. Clinical outcomes after aortic valve replacement with the Toronto stentless porcine valve. Ann Thorac Surg. 71:(Suppl):2001;S302-305
7. Cutrara C.A., Goldman B.S., Christakis G.T. Preferred method for insertion of the Toronto stentless porcine valve. J Card Surg. 13:1998;408-411
8. Cohen G., David T.E., Ivanov J., Armstrong S., Feindel C.M. The impact of age, coronary artery disease, and cardiac comorbidity on late survival after bioprosthetic aortic valve replacement. J Thorac Cardiovasc Surg. 117:1999;273-284
9. Edmunds L.H. Jr, Clark R.E., Cohn L.H., Grunkemeier G.L., Miller D.C., Weisel R.D. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity of The American Association for Thoracic Surgery and The Society of Thoracic Surgeons. J Thorac Cardiovasc Surg. 112:1996;708-771
10. Silberman S., Shaheen J., Fink D., et al. Comparison of exercise hemodynamics among nonstented aortic bioprostheses, mechanical valves, and normal native aortic valves. J Card Surg. 13:1998;412-416
11. Walther T., Falk V., Langebartels G., et al. Prospectively randomized evaluation of stentless versus conventional biological aortic valves impact on early regression of left ventricular hypertrophy. Circulation. 100:(Suppl):1999;II6-10
12. Dellgren G., David T.E., Raanani E., Armstrong S., Ivanov J., Rakowski H. Late hemodynamic and clinical outcomes of aortic valve replacement with the Carpentier-Edwards Perimount pericardial bioprosthesis. J Thorac Cardiovasc Surg. 124:2002;146-154
13. Banbury M.K., Cosgrove D.M. 3rd, Lytle B.W., Smedira N.G., Sabik J.F., Saunders C.R. Long-term results of the Carpentier-Edwards pericardial aortic valve a 12-year follow-up. Ann Thorac Surg. 66:(Suppl):1998;S73-76
14. David T.E., Ivanov J., Armstrong S., Feindel C.M., Cohen G. Late results of heart valve replacement with the Hancock II bioprosthesis. J Thorac Cardiovasc Surg. 121:2001;268-277
15. Rizzoli G., Bottio T., Thiene G., Toscano G., Casarotto D. Long-term durability of the Hancock II porcine bioprosthesis. J Thorac Cardiovasc Surg. 126:2003;66-74
16. Dellgren G., Feindel C.M., Bos J., Ivanov J., David T.E. Aortic valve replacement with the Toronto SPV long-term clinical and hemodynamic results. Eur J Cardiothorac Surg. 21:2002;698-702
17. Shargall Y., Goldman B., Christakis G., David T. Clinical Investigators of TSVP. Analysis of explants and causes of mortality during long-term follow-up of the Toronto stentless porcine valve. Semin Thorac Cardiovasc Surg. 13:(Suppl 1):2001;106-112
18. David T.E., Ivanov J., Eriksson M.J., Bos J., Feindel C.M., Rakowski H. Dilation of the sinotubular junction causes aortic insufficiency after aortic valve replacement with the Toronto SPV bioprosthesis. J Thorac Cardiovasc Surg. 122:2001;929-934
19. Christakis G.T., Buth K.J., Goldman B.S., et al. Inaccurate and misleading valve sizing a proposed standard for valve size nomenclature. Ann Thorac Surg. 66:1998;1198-1203
20. Schmid F.X., Bielenberg K., Schneider A., Haussler A., Keyser A., Birnbaum D. Ascending aortic aneurysm associated with bicuspid and tricuspid aortic valve involvement and clinical relevance of smooth muscle cell apoptosis and expression of cell death-initiating proteins. Eur J Cardiothorac Surg. 23:2003;537-543
21. Fedak P.W., de Sa M.P., Verma S., et al. Vascular matrix remodeling in patients with bicuspid aortic valve malformations implications for aortic dilatation. J Thorac Cardiovasc Surg. 126:2003;797-806
22. Bach D.S., Cartier P.C., Kon N.D., Johnson K.G., Deeb G.M., Doty D.B. Freestyle Valve Study Group. Impact of implant technique following freestyle stentless aortic valve replacement. Ann Thorac Surg. 74:2002;1107-1113
23. Butany J., de Sa M., Feindel C.M., David T.E. The Toronto SPV bioprosthesis review of morphological findings in eight valves. Semin Thorac Cardiovasc Surg. 11:(Suppl 1):1999;157-162
24. Flomenbaum M.A., Schoen F.J. Effects of fixation back pressure and antimineralization treatment on the morphology of porcine aortic bioprosthetic valves. J Thorac Cardiovasc Surg. 105:1993;154-164
25. Cunanan C.M., Cabiling C.M., Dinh T.T., et al. Tissue characterization and calcification potential of commercial bioprosthetic heart valves. Ann Thorac Surg. 71:(Suppl):2001;S417-421